Evidence map›Paper›PMID 32202747›Full record

ArticleJBRA assisted reproduction2020

Blastocysts Derived From 0PN Oocytes: Genetic And Clinical Results.

Maria Valeria Paz, Mariel Chiera, Paula Hovanyecz, Juliana Cicaré, Patricia Perfumo, Luciana Domenech, Viviana Ventura

Open access · bronzeAbstract read
In one paragraph

Article in JBRA assisted reproduction, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Could blastocysts derived from abnormal fertilized zygotes be used? A systematic review and meta-analysis.European journal of obstetrics & gynecology and reproductive biology: X · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Maria Valeria PazServicio de Medicina Reproductiva, Instituto Gamma, Rosario, Argentina.
Mariel ChieraServicio de Medicina Reproductiva, Instituto Gamma, Rosario, Argentina.
Paula HovanyeczServicio de Medicina Reproductiva, Instituto Gamma, Rosario, Argentina.
Juliana CicaréServicio de Medicina Reproductiva, Instituto Gamma, Rosario, Argentina.
Patricia PerfumoServicio de Medicina Reproductiva, Instituto Gamma, Rosario, Argentina.
Luciana DomenechServicio de Medicina Reproductiva, Instituto Gamma, Rosario, Argentina.
Viviana VenturaServicio de Medicina Reproductiva, Instituto Gamma, Rosario, Argentina.
Argentine Water and Sanitation (Argentina) · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyze the genetic and clinical outcomes of blastocysts derived from 0PN oocytes after IVF/ICSI.

methodsThis retrospective observational study included patients aged 40 years or younger submitted to IVF/ICSI with their own oocytes and with blastocysts derived from 0PN oocytes between January 2015 and April 2018. The clinical outcomes of 0PN blastocyst transfers were analyzed. Genetic tests were performed on biopsied 0PN blastocysts with Next Generation Sequencing.

resultsA total of 27 0PN blastocysts were transferred, yielding an implantation rate of 48.0% and an ongoing pregnancy rate of 50.0%. The transfers resulted in 13 live births (59.0% live birth rate). Genetic test results revealed that four of the 17 0PN blastocysts biopsied were 46XX; three were 46XY; and 10 were aneuploid embryos, awarding a diploid rate to 76.4% (13/17).

conclusionAlmost half of the 0PN blastocysts implanted (48.0%) and 13 healthy babies were born. More than three quarters (76.4%) of the 0PN blastocysts were diploid, thus ruling out the possibility of parthenogenetic activation. Our study indicated that the transfer of 0PN blastocysts is a safe, worthy option when the number of normal 2PN embryos is insufficient.

Indexed as

Embryo TransferOocytesPregnancy OutcomeAdultBlastocystDiploidyFemaleFertilization in VitroHumansPregnancyRetrospective StudiesTreatment Failure0PNblastocystdiploidyfertilization failureimplantation rate

Identifiers

PMID32202747
PMCPMC7169913
OpenAlexW3011607353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.